Eliana Clark |
eli*********@intelliatx.com
|
Intellia Therapeutics, Inc. |
Chief Technical Officer |
Biotechnology Research |
Cambridge, MA, US |
|
Irene Lau |
ire******@intelliatx.com
|
Intellia Therapeutics, Inc. |
Vice President of Business Development |
Biotechnology Research |
Cambridge, MA, US |
|
James Basta |
jam********@intelliatx.com
|
Intellia Therapeutics, Inc. |
Executive Vice President, General Counsel and Corporate Secretary |
Biotechnology Research |
Cambridge, MA, US |
|
Nicholas Marcantonio |
nic*****************@intelliatx.com
|
Intellia Therapeutics, Inc. |
|
Biotechnology Research |
Cambridge, MA, US |
|
Jeffrey Cehelsky |
jef*************@intelliatx.com
|
Intellia Therapeutics, Inc. |
Vice President of Development Operations |
Biotechnology Research |
Cambridge, MA, US |
|
Michael Lam |
mic********@intelliatx.com
|
Intellia Therapeutics, Inc. |
Vice President Immuno-Oncology |
Biotechnology Research |
Cambridge, MA, US |
|
Debashish Dey |
deb**********@intelliatx.com
|
Intellia Therapeutics, Inc. |
Vice President and Head, Drug Safety and Pharmacovigilance |
Biotechnology Research |
Cambridge, MA, US |
|
Laura Sepp-Lorenzino |
lau*****************@intelliatx.com
|
Intellia Therapeutics, Inc. |
Chief Scientific Officer |
Biotechnology Research |
Boston, Massachusetts, United States |
|
Raffaele Baffa |
raf**********@carsgen.com
|
carsgen.com |
Chief Medical Officer |
|
Boston, MA, US |
|
Jie J |
jie*@carsgen.com
|
carsgen.com |
VP of Strategic Alliances and Operations, Interim Head of CMC |
|
Durham, NC, US |
|